Clere AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A3H2309
EUR
11.80
-0.6 (-4.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.37 k

Shareholding (Jun 2013)

FII

0.00%

Held by 0 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 92 Million ()

stock-summary
P/E

70.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.12%

stock-summary
Debt Equity

-0.70

stock-summary
Return on Equity

0.94%

stock-summary
Price to Book

0.60

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Mar 2017)
Net Profit:
0 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.48%
0%
-2.48%
6 Months
1.72%
0%
1.72%
1 Year
-9.23%
0%
-9.23%
2 Years
-13.87%
0%
-13.87%
3 Years
-31.79%
0%
-31.79%
4 Years
-29.34%
0%
-29.34%
5 Years
-8.53%
0%
-8.53%

Clere AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-59.88%
EBIT Growth (5y)
13.87%
EBIT to Interest (avg)
-6.26
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.59
Sales to Capital Employed (avg)
0.21
Tax Ratio
20.18%
Dividend Payout Ratio
7.66%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
0
ROE (avg)
7.11%
Valuation key factors
Factor
Value
P/E Ratio
70
Industry P/E
Price to Book Value
0.66
EV to EBIT
-31.49
EV to EBITDA
-32.39
EV to Capital Employed
0.70
EV to Sales
122.96
PEG Ratio
0.61
Dividend Yield
1.94%
ROCE (Latest)
-2.23%
ROE (Latest)
0.94%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2013stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'17 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2017 is 0.00% vs -100.00% in Mar 2016",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2017 is 96.49% vs -914.29% in Mar 2016",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'17",
        "Mar'16",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.50",
          "val2": "-18.30",
          "chgp": "97.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "-5.70",
          "chgp": "96.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,633.60%",
          "val2": "0.00%",
          "chgp": "-163.36%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -7.07% vs 1.23% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 725.00% vs -33.33% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "46.00",
          "val2": "49.50",
          "chgp": "-7.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "29.60",
          "val2": "30.00",
          "chgp": "-1.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.30",
          "val2": "6.90",
          "chgp": "-23.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.40",
          "val2": "0.50",
          "chgp": "-20.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23.10",
          "val2": "2.80",
          "chgp": "725.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "280.70%",
          "val2": "216.30%",
          "chgp": "6.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'17 - YoYstock-summary
Mar'17
Mar'16
Change(%)
Net Sales
0.30
0.00
Operating Profit (PBDIT) excl Other Income
-0.50
-18.30
97.27%
Interest
0.00
0.00
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
-0.20
-5.70
96.49%
Operating Profit Margin (Excl OI)
-1,633.60%
0.00%
-163.36%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2017 is 0.00% vs -100.00% in Mar 2016

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2017 is 96.49% vs -914.29% in Mar 2016

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
46.00
49.50
-7.07%
Operating Profit (PBDIT) excl Other Income
29.60
30.00
-1.33%
Interest
5.30
6.90
-23.19%
Exceptional Items
0.40
0.50
-20.00%
Consolidate Net Profit
23.10
2.80
725.00%
Operating Profit Margin (Excl OI)
280.70%
216.30%
6.44%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -7.07% vs 1.23% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 725.00% vs -33.33% in Dec 2023

stock-summaryCompany CV
About Clere AG stock-summary
stock-summary
Clere AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available